Alterity Therapeutics Ltd (NASDAQ:ATHE)
| 1.71 Delayed Data As of Mar 01 |  +0.09 / +5.62%Today’s Change | 0.28 Today|||52-Week Range 5.15 | +27.61% Year-to-Date |
Latest ATHE News | Press Releases
No recent news for Alterity Therapeutics Ltd.
Today’s Trading
| Previous close | 1.60 |
| Today’s open | 1.66 |
| Day’s range | 1.60 - 1.71 |
| Volume | 245,518 |
| Average volume (3 months) | 1,923,811 |
| Market cap | $54.8M |
Data as of 3:59pm ET, 03/01/2021
Growth & Valuation
| Earnings growth (last year) | +29.65% |
| Earnings growth (this year) | -- |
| Earnings growth (next 5 years) | +2.00% |
| Revenue growth (last year) | -- |
| P/E ratio | NM |
| Price/Sales | -- |
| Price/Book | 5.69 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| ACORAcorda Therapeutics ... | +0.13 | +2.23% |
| SSKNSTRATA Skin Sciences... | -0.10 | -5.46% |
| OPNTOpiant Pharmaceutica... | +0.46 | +3.63% |
| CATBCatabasis Pharmaceut... | +0.14 | +4.86% |
Data as of 4:38pm ET, 03/01/2021
Financials
| Next reporting date | -- |
| EPS forecast (this quarter) | -- |
| Annual revenue (last year) | $0.00 |
| Annual profit (last year) | -$9.0M |
| Net profit margin | -- |
Profile
Sector Health Technology |
Industry Biotechnology |
No executives to display |
Corporate headquarters Melbourne, Victoria (vic) |
Forecasts
